STRIVE Trademark

Trademark Overview


On Tuesday, July 18, 2023, a trademark application was filed for STRIVE with the United States Patent and Trademark Office. The USPTO has given the STRIVE trademark a serial number of 98975541. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Thursday, September 5, 2024. This trademark is owned by Embecta Corp.. The STRIVE trademark is filed in the Medical Instrument Products category with the following description:

Medical devices and apparatus in the field of diabetes, namely, medical devices and apparatus for measuring blood glucose levels and injecting insulin; Medical devices for monitoring blood glucose levels and administering insulin therapy; Medical devices, namely, diabetes management devices, infusion pumps, infusion pump controllers and parts and attachments thereof; Medical devices for insulin therapy, namely, patch pumps for administering continuous subcutaneous insulin infusion; Medical devices, namely, wearable subcutaneous drug delivery devices, sold empty, in the nature of on-body injectors, insulin injectors, infusion pumps, insulin pumps, patch pumps, and controllers, component parts, and attachments therefor; Medical venous access ports, lancets, needles for medical use, syringes for medical use; Pen needles used to deliver medications to manage diabetes; Infusion sets; Infusion pump accessories, namely, belt clips specifically designed for holding infusion pumps and infusion ...
strive

General Information


Serial Number98975541
Word MarkSTRIVE
Filing DateTuesday, July 18, 2023
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateThursday, September 5, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesMedical devices and apparatus in the field of diabetes, namely, medical devices and apparatus for measuring blood glucose levels and injecting insulin; Medical devices for monitoring blood glucose levels and administering insulin therapy; Medical devices, namely, diabetes management devices, infusion pumps, infusion pump controllers and parts and attachments thereof; Medical devices for insulin therapy, namely, patch pumps for administering continuous subcutaneous insulin infusion; Medical devices, namely, wearable subcutaneous drug delivery devices, sold empty, in the nature of on-body injectors, insulin injectors, infusion pumps, insulin pumps, patch pumps, and controllers, component parts, and attachments therefor; Medical venous access ports, lancets, needles for medical use, syringes for medical use; Pen needles used to deliver medications to manage diabetes; Infusion sets; Infusion pump accessories, namely, belt clips specifically designed for holding infusion pumps and infusion sets; Subcutaneous infusion sets for use by diabetes patients in connection with insulin pumps; Infusion pumps; Insulin pumps; Infusion and insulin pump accessories, namely, medical sensors, meters, and medical devices for measuring and monitoring blood and urine properties; Medical devices and medical apparatus for measuring and monitoring blood and urine properties; Glucose meters; Blood glucose meters; Medical apparatus for monitoring blood glucose levels; Medical apparatus and instruments for monitoring glucose; Continuous glucose monitoring systems comprised of a medical apparatus for monitoring glucose; Sensor-based glucose monitors for medical purposes; Blood glucose monitoring systems including blood glucose monitors, and parts and accessories therefor, namely, blood glucose monitoring carrying cases, and electronic blood glucose test diaries in the nature of integrated computer memory devices within blood glucose monitors; Devices for monitoring blood glucose for medical purposes; Devices for measuring blood sugar; Medical devices, namely, medical sensors that are implanted and inserted into the human body used to continuously monitor the concentration of glucose in the human body and accessories therefor, namely, data receivers, sensor housings and sensor insertion devices; Medical diagnostic apparatus for testing blood sugar levels incorporating recorded software for the collection, editing, organizing, modifying, transmission, storage and sharing of medical information; Medical devices and apparatus in the field of diabetes, namely, diabetes management devices featuring software and computer hardware for collecting, presenting, controlling, analyzing, reporting, storing, transmitting and managing medical information, patient information, patient care information and information about tracking the medicines of patients; Medical devices and apparatus in the field of diabetes, namely, diabetes management devices featuring software and computer hardware for controlling and managing patient medical information; Medical devices and apparatus in the field of diabetes, namely, diabetes management devices featuring software and computer hardware for collecting, editing, organizing, modifying, transmitting, storing, and sharing patient care instructions and medical information; Medical devices and apparatus in the field of diabetes, namely, diabetes management devices featuring software and computer hardware for acquiring, analyzing, transmitting and storing medical and physiological data; Medical devices and apparatus in the field of diabetes, namely, diabetes management devices featuring software and computer hardware for viewing, sharing, reporting, maintaining, managing, monitoring, and analyzing data and information in the fields of nutrition, health and wellness, and diabetes treatment and management; Medical devices and apparatus in the field of diabetes, namely, diabetes management devices featuring software and computer hardware for collection, presentation, control, analysis, reporting, storage, transmission and management of data for use in the field of digital therapeutics; Medical devices and apparatus in the field of diabetes, namely, diabetes management devices featuring software and computer hardware for use in the treatment and management of diabetes; Medical devices and apparatus in the field of diabetes, namely, diabetes management devices featuring software and computer hardware for linking medical instruments and devices for use in the treatment and management of diabetes; Medical devices and apparatus in the field of diabetes, namely, diabetes management devices featuring software and computer hardware for collecting, editing, organizing, modifying, transmitting, storing, and sharing patient care instructions and medical information for providing non-medical interventions, namely, alerts about blood glucose levels, physical activity, injections, and medication adherence for individuals in the treatment and management of diabetes; Medical devices and apparatus in the field of diabetes, namely, diabetes management devices featuring software and computer hardware for collecting, editing, organizing, modifying, transmitting, storing, and sharing patient care instructions and medical information for preparing and delivering reports and analytics relating to medical and physiological data in the treatment and management of diabetes; Medical devices and apparatus in the field of diabetes, namely, diabetes management devices featuring software and computer hardware for monitoring blood glucose in connection with blood glucose monitors; Medical devices and apparatus in the field of diabetes, namely, diabetes management devices featuring software and computer hardware for controlling insulin delivery in connection with insulin pumps; Medical devices and apparatus in the field of diabetes, namely, diabetes management devices featuring software and computer hardware for capturing, storing, processing, controlling, analyzing, managing, tracking, monitoring, and transmitting patient medical data from medical devices, namely, wearable medical devices, insulin pumps and glucose monitors; Medical devices and apparatus in the field of diabetes, namely, diabetes management devices featuring software and computer hardware for obtaining, controlling, and managing patient medical information on wearable medical devices; Medical devices and apparatus in the field of diabetes, namely, diabetes management devices featuring software and computer hardware for controlling and managing wearable insulin delivery devices; Medical devices and apparatus in the field of diabetes, namely, diabetes management devices featuring software and computer hardware used to display, manage, and monitor diabetes management information

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, August 16, 2023
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEmbecta Corp.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressParsippany, NJ 07054

Trademark Events


Event DateEvent Description
Friday, July 21, 2023NEW APPLICATION ENTERED
Wednesday, August 16, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 5, 2024NON-FINAL ACTION WRITTEN
Friday, March 1, 2024ASSIGNED TO EXAMINER
Tuesday, March 5, 2024NON-FINAL ACTION E-MAILED
Thursday, May 16, 2024TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, June 4, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Thursday, September 5, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 5, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 5, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 12, 2025DIVISIONAL PROCESSING COMPLETE
Tuesday, March 5, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 4, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Thursday, May 16, 2024DIVISIONAL REQUEST RECEIVED
Wednesday, February 12, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL